Insider Selling: Adtalem Global Education (NYSE:CVSA) CEO Sells 15,874 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 15,874 shares of the company’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $131.25, for a total transaction of $2,083,462.50. Following the completion of the sale, the chief executive officer owned 429,324 shares in the company, valued at $56,348,775. This represents a 3.57% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Down 1.5%

Shares of CVSA traded down $1.96 on Tuesday, reaching $128.28. The company’s stock had a trading volume of 239,676 shares, compared to its average volume of 392,864. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.36. Adtalem Global Education Inc. has a twelve month low of $86.97 and a twelve month high of $156.26. The firm has a market cap of $4.37 billion, a PE ratio of 19.98, a PEG ratio of 1.11 and a beta of 0.63. The company has a fifty day moving average of $111.84.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The company had revenue of $487.03 million for the quarter. During the same quarter in the prior year, the company earned $1.92 EPS. The company’s revenue was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, equities analysts anticipate that Adtalem Global Education Inc. will post 8.05 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on CVSA shares. Barrington Research restated an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a report on Friday, April 17th. Wall Street Zen lowered shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a report on Saturday. Zacks Research lowered shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Weiss Ratings started coverage on shares of Adtalem Global Education in a report on Wednesday, February 25th. They issued a “hold (c+)” rating on the stock. Finally, Truist Financial upped their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Adtalem Global Education presently has a consensus rating of “Moderate Buy” and an average price target of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.